221 related articles for article (PubMed ID: 9193800)
1. Controlling elements in replication of the human immunodeficiency virus type 1.
Li X; Quan Y; Wainberg MA
Cell Mol Biol (Noisy-le-grand); 1997 May; 43(3):443-54. PubMed ID: 9193800
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.
Mautino MR; Keiser N; Morgan RA
J Virol; 2001 Apr; 75(8):3590-9. PubMed ID: 11264348
[TBL] [Abstract][Full Text] [Related]
3. Regulation of expression of human immunodeficiency virus.
Pavlakis GN; Felber BK
New Biol; 1990 Jan; 2(1):20-31. PubMed ID: 2078551
[TBL] [Abstract][Full Text] [Related]
4. Tat and rev differentially affect restricted replication of human immunodeficiency virus type 1 in various cells.
Duan L; Oakes JW; Ferraro A; Bagasra O; Pomerantz RJ
Virology; 1994 Mar; 199(2):474-8. PubMed ID: 8122376
[TBL] [Abstract][Full Text] [Related]
5. Regulation of HIV-1 envelope protein synthesis by Tat and Rev in 293 cells.
Natarajan V; Radjendirane V; Salzman NP
Virology; 1993 Sep; 196(1):122-9. PubMed ID: 8356789
[TBL] [Abstract][Full Text] [Related]
6. RNA-sequence-mediated gene regulation in HIV-1.
Cullen BR
Infect Agents Dis; 1994; 3(2-3):68-76. PubMed ID: 7812657
[TBL] [Abstract][Full Text] [Related]
7. Genetic organization of a chimpanzee lentivirus related to HIV-1.
Huet T; Cheynier R; Meyerhans A; Roelants G; Wain-Hobson S
Nature; 1990 May; 345(6273):356-9. PubMed ID: 2188136
[TBL] [Abstract][Full Text] [Related]
8. The tripeptide glycyl-prolyl-glycine amide does not affect the early steps of the human immunodeficiency virus type 1 replication.
Su J; Naghavi MH; Jejcic A; Horal P; Furuta Y; Wu YP; Li SL; Hall WW; Goobar-Larsson L; Svennerholm B; Vahlne A
J Hum Virol; 2001; 4(1):8-15. PubMed ID: 11213934
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human immunodeficiency virus type 1 replication is enhanced by a combination of transdominant Tat and Rev proteins.
Ulich C; Harrich D; Estes P; Gaynor RB
J Virol; 1996 Jul; 70(7):4871-6. PubMed ID: 8676525
[TBL] [Abstract][Full Text] [Related]
10. [RNA ligands for HIV proteins].
Iwai S
Tanpakushitsu Kakusan Koso; 1995 Jul; 40(10):1430-7. PubMed ID: 7568944
[No Abstract] [Full Text] [Related]
11. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of HIV-1 by a double transdominant fusion gene.
Aguilar-Cordova E; Chinen J; Donehower LA; Harper JW; Rice AP; Butel JS; Belmont JW
Gene Ther; 1995 May; 2(3):181-6. PubMed ID: 7614248
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 gag proteins: diverse functions in the virus life cycle.
Freed EO
Virology; 1998 Nov; 251(1):1-15. PubMed ID: 9813197
[TBL] [Abstract][Full Text] [Related]
14. Molecular biology of HIV-1: positive and negative regulatory elements important for virus expression.
Felber BK; Pavlakis GN
AIDS; 1993; 7 Suppl 1():S51-62. PubMed ID: 8363803
[No Abstract] [Full Text] [Related]
15. Inhibition of HIV-1 replication by combined expression of gag dominant negative mutant and a human ribonuclease in a tightly controlled HIV-1 inducible vector.
Cara A; Rybak SM; Newton DL; Crowley R; Rottschafer SE; Reitz MS; Gusella GL
Gene Ther; 1998 Jan; 5(1):65-75. PubMed ID: 9536266
[TBL] [Abstract][Full Text] [Related]
16. Viral factors involved in adapter-related protein complex 2 alpha 1 subunit-mediated regulation of human immunodeficiency virus type 1 replication.
Sapsutthipas S; Kitagawa Y; Tokunaga K; Ikuta K; Kameoka M
Southeast Asian J Trop Med Public Health; 2011 Mar; 42(2):311-9. PubMed ID: 21710851
[TBL] [Abstract][Full Text] [Related]
17. The role of Tat in HIV-1 replication: an activator and/or a suppressor?
Liang C; Wainberg MA
AIDS Rev; 2002; 4(1):41-9. PubMed ID: 11998784
[TBL] [Abstract][Full Text] [Related]
18. A new RNA element located in the coding region of a murine endogenous retrovirus can functionally replace the Rev/Rev-responsive element system in human immunodeficiency virus type 1 Gag expression.
Wodrich H; Bohne J; Gumz E; Welker R; Kräusslich HG
J Virol; 2001 Nov; 75(22):10670-82. PubMed ID: 11602709
[TBL] [Abstract][Full Text] [Related]
19. A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAs, and trans-dominant negative mutant Gag and Env proteins.
Ding SF; Lombardi R; Nazari R; Joshi S
Front Biosci; 2002 Feb; 7():a15-28. PubMed ID: 11815282
[TBL] [Abstract][Full Text] [Related]
20. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
